Brousseau ME - Search Results

1

Identification of a PCSK9-LDLR disruptor peptide with in vivo function.

Brousseau ME, Clairmont KB, Spraggon G, Flyer AN, Golosov AA, Grosche P, Amin J, Andre J, Burdick D, Caplan S, Chen G, Chopra R, Ames L, Dubiel D, Fan L, Gattlen R, Kelly-Sullivan D, Koch AW, Lewis I, Li J, Liu E, Lubicka D, Marzinzik A, Nakajima K, Nettleton D, Ottl J, Pan M, Patel T, Perry L, Pickett S, Poirier J, Reid PC, Pelle X, Seepersaud M, Subramanian V, Vera V, Xu M, Yang L, Yang Q, Yu J, Zhu G, Monovich LG. Brousseau ME, et al. Cell Chem Biol. 2022 Feb 17;29(2):249-258.e5. doi: 10.1016/j.chembiol.2021.08.012. Epub 2021 Sep 20. Cell Chem Biol. 2022. PMID: 34547225 Free article.

2

Synthetic phospholipids as specific substrates for plasma endothelial lipase.

Papillon JP, Pan M, Brousseau ME, Gilchrist MA, Lou C, Singh AK, Stawicki T, Thompson JE. Papillon JP, et al. Among authors: brousseau me. Bioorg Med Chem Lett. 2016 Aug 1;26(15):3514-7. doi: 10.1016/j.bmcl.2016.06.032. Epub 2016 Jun 14. Bioorg Med Chem Lett. 2016. PMID: 27344207

3

Discovery of a Novel Piperidine-Based Inhibitor of Cholesteryl Ester Transfer Protein (CETP) That Retains Activity in Hypertriglyceridemic Plasma.

Yamada K, Brousseau M, Honma W, Iimura A, Imase H, Iwaki Y, Kawanami T, LaSala D, Liang G, Mitani H, Nonomura K, Ohmori O, Pan M, Rigel DF, Umemura I, Yasoshima K, Zhu G, Mogi M. Yamada K, et al. J Med Chem. 2017 Oct 26;60(20):8466-8481. doi: 10.1021/acs.jmedchem.7b00900. Epub 2017 Oct 16. J Med Chem. 2017. PMID: 29035537

4

Statins, super-statins and cholesterol absorption inhibitors.

Brousseau ME. Brousseau ME. IDrugs. 2003 May;6(5):458-63. IDrugs. 2003. PMID: 12789600 Review.

5

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.

Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Brousseau ME, et al. N Engl J Med. 2004 Apr 8;350(15):1505-15. doi: 10.1056/NEJMoa031766. N Engl J Med. 2004. PMID: 15071125 Free article. Clinical Trial.

6

Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Brousseau ME, Millar JS, Diffenderfer MR, Nartsupha C, Asztalos BF, Wolfe ML, Mancuso JP, Digenio AG, Rader DJ, Schaefer EJ. Brousseau ME, et al. J Lipid Res. 2009 Jul;50(7):1456-62. doi: 10.1194/jlr.P800037-JLR200. Epub 2009 Feb 3. J Lipid Res. 2009. PMID: 19193611 Free PMC article. Clinical Trial.

7

New targets for medical treatment of lipid disorders.

Brousseau ME, Schaefer EJ. Brousseau ME, et al. Curr Atheroscler Rep. 2002 Sep;4(5):343-9. doi: 10.1007/s11883-002-0071-x. Curr Atheroscler Rep. 2002. PMID: 12162933 Review.

8

New developments in the prevention of atherosclerosis in patients with low high-density lipoprotein cholesterol.

Brousseau ME, Schaefer EJ. Brousseau ME, et al. Curr Atheroscler Rep. 2001 Sep;3(5):365-72. doi: 10.1007/s11883-001-0074-z. Curr Atheroscler Rep. 2001. PMID: 11487447 Review.

9

HDL Cholesterol - Third Annual International Conference. Metabolic Pathways and Drug Development. 25-26 February 2002, Boston, MA, USA.

Brousseau ME. Brousseau ME. IDrugs. 2002 Apr;5(4):327-30. IDrugs. 2002. PMID: 15565512

10

ATP-binding cassette transporter A1, fatty acids, and cholesterol absorption.

Brousseau ME. Brousseau ME. Curr Opin Lipidol. 2003 Feb;14(1):35-40. doi: 10.1097/00041433-200302000-00007. Curr Opin Lipidol. 2003. PMID: 12544659 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page